Loading…
Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum
Background/Objectives Molluscum contagiosum is the most common skin infection in children. One topical treatment used for Molluscum contagiosum is potassium hydroxide. The objective of this study was to compare the efficacy of potassium hydroxide topical treatment at different concentrations with th...
Saved in:
Published in: | Pediatric dermatology 2018-05, Vol.35 (3), p.336-342 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3538-f1084bf7ade87e211cc4758f00051b9be9170238eccf822f2fb79601c6430af43 |
---|---|
cites | cdi_FETCH-LOGICAL-c3538-f1084bf7ade87e211cc4758f00051b9be9170238eccf822f2fb79601c6430af43 |
container_end_page | 342 |
container_issue | 3 |
container_start_page | 336 |
container_title | Pediatric dermatology |
container_volume | 35 |
creator | Teixidó, Concepció Díez, Olga Marsal, Josep R. Giner‐Soriano, Maria Pera, Helena Martinez, Mireia Galindo‐Ortego, Gisela Schoenenberger, Joan A. Real, Jordi Cruz, Ines Morros, Rosa |
description | Background/Objectives
Molluscum contagiosum is the most common skin infection in children. One topical treatment used for Molluscum contagiosum is potassium hydroxide. The objective of this study was to compare the efficacy of potassium hydroxide topical treatment at different concentrations with that of placebo in terms of complete clearing of Molluscum contagiosum lesions and to assess the safety and tolerance of potassium hydroxide topical treatment.
Methods
This was a double‐blind randomized clinical trial of three treatments (potassium hydroxide 10%, potassium hydroxide 15%, placebo) applied once daily up to complete clearing of lesions (maximum duration 60 days) in 53 children aged 2‐6 years in primary health care pediatric offices in Catalonia, Spain.
Results
In the intention‐to‐treat analysis, potassium hydroxide 10% (58.8%, P = .03) and potassium hydroxide 15% (64.3%, P = .02) had efficacy superior to that of placebo (18.8%). The number of Molluscum contagiosum lesions was significantly reduced with potassium hydroxide 10% and 15%. The main efficacy outcome was achieved in 58.8% of children in the potassium hydroxide 10% group (P = .03 vs placebo) and in 64.3% of children in the potassium hydroxide 15% group (P = .02 vs placebo). Potassium hydroxide 10% and 15% were not significantly different in efficacy from each other. Potassium hydroxide 10% and placebo were better tolerated than potassium hydroxide 15%. No adverse events were reported during the study period.
Conclusions
Potassium hydroxide 10% and 15% demonstrated high rates of efficacy in clearing Molluscum contagiosum lesions, with potassium hydroxide 10% being better tolerated. |
doi_str_mv | 10.1111/pde.13438 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2008361524</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2008361524</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3538-f1084bf7ade87e211cc4758f00051b9be9170238eccf822f2fb79601c6430af43</originalsourceid><addsrcrecordid>eNp10ctO3DAUBmCrKioD7aIvUFmqRiqLgC_xJUsEA1QCwaJdR45zDEFJnNqOIG9fD0NZINUbW0eff9nnIPSVkmOa18nUwjHlJdcf0IoKJgpaKvIRrYjistCklPvoIMZHQoiWkn5C-6wqVaWYWqHnjXOdNXbBZmxxNA7Sgr3DyU-53GMzTX0-pM6P2zIV6xdIyRpPPpkYu3nAD0sb_HPXAnY-4PQAOAUwaYAxbS_d-L6fo83Q-jGZ-87HefiM9pzpI3x53Q_R74vNr7Or4vr28ufZ6XVhueC6cJTosnHKtKAVMEqtLZXQLv9F0KZqoKKKMK7BWqcZc8w1qpKEWllyYlzJD9GPXe4U_J8ZYqqHLlroezOCn2PNclO4zF3b0u_v6KOfw5hflxWXlRRCVFkd7ZQNPsYArp5CN5iw1JTU23HUeRz1yziy_faaODcDtG_yX_8zONmBp66H5f9J9d35Zhf5F66mkzw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2036965559</pqid></control><display><type>article</type><title>Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Teixidó, Concepció ; Díez, Olga ; Marsal, Josep R. ; Giner‐Soriano, Maria ; Pera, Helena ; Martinez, Mireia ; Galindo‐Ortego, Gisela ; Schoenenberger, Joan A. ; Real, Jordi ; Cruz, Ines ; Morros, Rosa</creator><creatorcontrib>Teixidó, Concepció ; Díez, Olga ; Marsal, Josep R. ; Giner‐Soriano, Maria ; Pera, Helena ; Martinez, Mireia ; Galindo‐Ortego, Gisela ; Schoenenberger, Joan A. ; Real, Jordi ; Cruz, Ines ; Morros, Rosa</creatorcontrib><description>Background/Objectives
Molluscum contagiosum is the most common skin infection in children. One topical treatment used for Molluscum contagiosum is potassium hydroxide. The objective of this study was to compare the efficacy of potassium hydroxide topical treatment at different concentrations with that of placebo in terms of complete clearing of Molluscum contagiosum lesions and to assess the safety and tolerance of potassium hydroxide topical treatment.
Methods
This was a double‐blind randomized clinical trial of three treatments (potassium hydroxide 10%, potassium hydroxide 15%, placebo) applied once daily up to complete clearing of lesions (maximum duration 60 days) in 53 children aged 2‐6 years in primary health care pediatric offices in Catalonia, Spain.
Results
In the intention‐to‐treat analysis, potassium hydroxide 10% (58.8%, P = .03) and potassium hydroxide 15% (64.3%, P = .02) had efficacy superior to that of placebo (18.8%). The number of Molluscum contagiosum lesions was significantly reduced with potassium hydroxide 10% and 15%. The main efficacy outcome was achieved in 58.8% of children in the potassium hydroxide 10% group (P = .03 vs placebo) and in 64.3% of children in the potassium hydroxide 15% group (P = .02 vs placebo). Potassium hydroxide 10% and 15% were not significantly different in efficacy from each other. Potassium hydroxide 10% and placebo were better tolerated than potassium hydroxide 15%. No adverse events were reported during the study period.
Conclusions
Potassium hydroxide 10% and 15% demonstrated high rates of efficacy in clearing Molluscum contagiosum lesions, with potassium hydroxide 10% being better tolerated.</description><identifier>ISSN: 0736-8046</identifier><identifier>EISSN: 1525-1470</identifier><identifier>DOI: 10.1111/pde.13438</identifier><identifier>PMID: 29479727</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Children ; Clinical trials ; efficacy ; Molluscum contagiosum ; Motivation ; paediatrics ; Pediatrics ; Potash ; Potassium ; Potassium hydroxide ; randomized clinical trial ; safety ; Skin ; Skin diseases ; skin infections ; Supply & demand ; Topical application ; Viral infections</subject><ispartof>Pediatric dermatology, 2018-05, Vol.35 (3), p.336-342</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>Copyright © 2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3538-f1084bf7ade87e211cc4758f00051b9be9170238eccf822f2fb79601c6430af43</citedby><cites>FETCH-LOGICAL-c3538-f1084bf7ade87e211cc4758f00051b9be9170238eccf822f2fb79601c6430af43</cites><orcidid>0000-0003-3750-9233</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29479727$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Teixidó, Concepció</creatorcontrib><creatorcontrib>Díez, Olga</creatorcontrib><creatorcontrib>Marsal, Josep R.</creatorcontrib><creatorcontrib>Giner‐Soriano, Maria</creatorcontrib><creatorcontrib>Pera, Helena</creatorcontrib><creatorcontrib>Martinez, Mireia</creatorcontrib><creatorcontrib>Galindo‐Ortego, Gisela</creatorcontrib><creatorcontrib>Schoenenberger, Joan A.</creatorcontrib><creatorcontrib>Real, Jordi</creatorcontrib><creatorcontrib>Cruz, Ines</creatorcontrib><creatorcontrib>Morros, Rosa</creatorcontrib><title>Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum</title><title>Pediatric dermatology</title><addtitle>Pediatr Dermatol</addtitle><description>Background/Objectives
Molluscum contagiosum is the most common skin infection in children. One topical treatment used for Molluscum contagiosum is potassium hydroxide. The objective of this study was to compare the efficacy of potassium hydroxide topical treatment at different concentrations with that of placebo in terms of complete clearing of Molluscum contagiosum lesions and to assess the safety and tolerance of potassium hydroxide topical treatment.
Methods
This was a double‐blind randomized clinical trial of three treatments (potassium hydroxide 10%, potassium hydroxide 15%, placebo) applied once daily up to complete clearing of lesions (maximum duration 60 days) in 53 children aged 2‐6 years in primary health care pediatric offices in Catalonia, Spain.
Results
In the intention‐to‐treat analysis, potassium hydroxide 10% (58.8%, P = .03) and potassium hydroxide 15% (64.3%, P = .02) had efficacy superior to that of placebo (18.8%). The number of Molluscum contagiosum lesions was significantly reduced with potassium hydroxide 10% and 15%. The main efficacy outcome was achieved in 58.8% of children in the potassium hydroxide 10% group (P = .03 vs placebo) and in 64.3% of children in the potassium hydroxide 15% group (P = .02 vs placebo). Potassium hydroxide 10% and 15% were not significantly different in efficacy from each other. Potassium hydroxide 10% and placebo were better tolerated than potassium hydroxide 15%. No adverse events were reported during the study period.
Conclusions
Potassium hydroxide 10% and 15% demonstrated high rates of efficacy in clearing Molluscum contagiosum lesions, with potassium hydroxide 10% being better tolerated.</description><subject>Children</subject><subject>Clinical trials</subject><subject>efficacy</subject><subject>Molluscum contagiosum</subject><subject>Motivation</subject><subject>paediatrics</subject><subject>Pediatrics</subject><subject>Potash</subject><subject>Potassium</subject><subject>Potassium hydroxide</subject><subject>randomized clinical trial</subject><subject>safety</subject><subject>Skin</subject><subject>Skin diseases</subject><subject>skin infections</subject><subject>Supply & demand</subject><subject>Topical application</subject><subject>Viral infections</subject><issn>0736-8046</issn><issn>1525-1470</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp10ctO3DAUBmCrKioD7aIvUFmqRiqLgC_xJUsEA1QCwaJdR45zDEFJnNqOIG9fD0NZINUbW0eff9nnIPSVkmOa18nUwjHlJdcf0IoKJgpaKvIRrYjistCklPvoIMZHQoiWkn5C-6wqVaWYWqHnjXOdNXbBZmxxNA7Sgr3DyU-53GMzTX0-pM6P2zIV6xdIyRpPPpkYu3nAD0sb_HPXAnY-4PQAOAUwaYAxbS_d-L6fo83Q-jGZ-87HefiM9pzpI3x53Q_R74vNr7Or4vr28ufZ6XVhueC6cJTosnHKtKAVMEqtLZXQLv9F0KZqoKKKMK7BWqcZc8w1qpKEWllyYlzJD9GPXe4U_J8ZYqqHLlroezOCn2PNclO4zF3b0u_v6KOfw5hflxWXlRRCVFkd7ZQNPsYArp5CN5iw1JTU23HUeRz1yziy_faaODcDtG_yX_8zONmBp66H5f9J9d35Zhf5F66mkzw</recordid><startdate>201805</startdate><enddate>201805</enddate><creator>Teixidó, Concepció</creator><creator>Díez, Olga</creator><creator>Marsal, Josep R.</creator><creator>Giner‐Soriano, Maria</creator><creator>Pera, Helena</creator><creator>Martinez, Mireia</creator><creator>Galindo‐Ortego, Gisela</creator><creator>Schoenenberger, Joan A.</creator><creator>Real, Jordi</creator><creator>Cruz, Ines</creator><creator>Morros, Rosa</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3750-9233</orcidid></search><sort><creationdate>201805</creationdate><title>Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum</title><author>Teixidó, Concepció ; Díez, Olga ; Marsal, Josep R. ; Giner‐Soriano, Maria ; Pera, Helena ; Martinez, Mireia ; Galindo‐Ortego, Gisela ; Schoenenberger, Joan A. ; Real, Jordi ; Cruz, Ines ; Morros, Rosa</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3538-f1084bf7ade87e211cc4758f00051b9be9170238eccf822f2fb79601c6430af43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Children</topic><topic>Clinical trials</topic><topic>efficacy</topic><topic>Molluscum contagiosum</topic><topic>Motivation</topic><topic>paediatrics</topic><topic>Pediatrics</topic><topic>Potash</topic><topic>Potassium</topic><topic>Potassium hydroxide</topic><topic>randomized clinical trial</topic><topic>safety</topic><topic>Skin</topic><topic>Skin diseases</topic><topic>skin infections</topic><topic>Supply & demand</topic><topic>Topical application</topic><topic>Viral infections</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Teixidó, Concepció</creatorcontrib><creatorcontrib>Díez, Olga</creatorcontrib><creatorcontrib>Marsal, Josep R.</creatorcontrib><creatorcontrib>Giner‐Soriano, Maria</creatorcontrib><creatorcontrib>Pera, Helena</creatorcontrib><creatorcontrib>Martinez, Mireia</creatorcontrib><creatorcontrib>Galindo‐Ortego, Gisela</creatorcontrib><creatorcontrib>Schoenenberger, Joan A.</creatorcontrib><creatorcontrib>Real, Jordi</creatorcontrib><creatorcontrib>Cruz, Ines</creatorcontrib><creatorcontrib>Morros, Rosa</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Teixidó, Concepció</au><au>Díez, Olga</au><au>Marsal, Josep R.</au><au>Giner‐Soriano, Maria</au><au>Pera, Helena</au><au>Martinez, Mireia</au><au>Galindo‐Ortego, Gisela</au><au>Schoenenberger, Joan A.</au><au>Real, Jordi</au><au>Cruz, Ines</au><au>Morros, Rosa</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum</atitle><jtitle>Pediatric dermatology</jtitle><addtitle>Pediatr Dermatol</addtitle><date>2018-05</date><risdate>2018</risdate><volume>35</volume><issue>3</issue><spage>336</spage><epage>342</epage><pages>336-342</pages><issn>0736-8046</issn><eissn>1525-1470</eissn><abstract>Background/Objectives
Molluscum contagiosum is the most common skin infection in children. One topical treatment used for Molluscum contagiosum is potassium hydroxide. The objective of this study was to compare the efficacy of potassium hydroxide topical treatment at different concentrations with that of placebo in terms of complete clearing of Molluscum contagiosum lesions and to assess the safety and tolerance of potassium hydroxide topical treatment.
Methods
This was a double‐blind randomized clinical trial of three treatments (potassium hydroxide 10%, potassium hydroxide 15%, placebo) applied once daily up to complete clearing of lesions (maximum duration 60 days) in 53 children aged 2‐6 years in primary health care pediatric offices in Catalonia, Spain.
Results
In the intention‐to‐treat analysis, potassium hydroxide 10% (58.8%, P = .03) and potassium hydroxide 15% (64.3%, P = .02) had efficacy superior to that of placebo (18.8%). The number of Molluscum contagiosum lesions was significantly reduced with potassium hydroxide 10% and 15%. The main efficacy outcome was achieved in 58.8% of children in the potassium hydroxide 10% group (P = .03 vs placebo) and in 64.3% of children in the potassium hydroxide 15% group (P = .02 vs placebo). Potassium hydroxide 10% and 15% were not significantly different in efficacy from each other. Potassium hydroxide 10% and placebo were better tolerated than potassium hydroxide 15%. No adverse events were reported during the study period.
Conclusions
Potassium hydroxide 10% and 15% demonstrated high rates of efficacy in clearing Molluscum contagiosum lesions, with potassium hydroxide 10% being better tolerated.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>29479727</pmid><doi>10.1111/pde.13438</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-3750-9233</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0736-8046 |
ispartof | Pediatric dermatology, 2018-05, Vol.35 (3), p.336-342 |
issn | 0736-8046 1525-1470 |
language | eng |
recordid | cdi_proquest_miscellaneous_2008361524 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Children Clinical trials efficacy Molluscum contagiosum Motivation paediatrics Pediatrics Potash Potassium Potassium hydroxide randomized clinical trial safety Skin Skin diseases skin infections Supply & demand Topical application Viral infections |
title | Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T23%3A39%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20and%20safety%20of%20topical%20application%20of%2015%25%20and%2010%25%20potassium%20hydroxide%20for%20the%20treatment%20of%20Molluscum%20contagiosum&rft.jtitle=Pediatric%20dermatology&rft.au=Teixid%C3%B3,%20Concepci%C3%B3&rft.date=2018-05&rft.volume=35&rft.issue=3&rft.spage=336&rft.epage=342&rft.pages=336-342&rft.issn=0736-8046&rft.eissn=1525-1470&rft_id=info:doi/10.1111/pde.13438&rft_dat=%3Cproquest_cross%3E2008361524%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3538-f1084bf7ade87e211cc4758f00051b9be9170238eccf822f2fb79601c6430af43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2036965559&rft_id=info:pmid/29479727&rfr_iscdi=true |